DarioHealth Corp. Proceeds from Issuance or Sale of Equity
DarioHealth Corp. (DRIO) reported Proceeds from Issuance or Sale of Equity of $6.75 million for the 6-month period ending 2025-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOrSaleOfEquity · last filed 2026-08-11
- DarioHealth Corp. proceeds from issuance or sale of equity for the quarter ending 2020-12-31 was $0.00, a 100.00% decline year-over-year.
- DarioHealth Corp. proceeds from issuance or sale of equity for the quarter ending 2020-09-30 was $27.55M.
- DarioHealth Corp. proceeds from issuance or sale of equity for the quarter ending 2019-12-31 was $18.69M.
- DarioHealth Corp. proceeds from issuance or sale of equity for the quarter ending 2019-09-30 was $0.00.
- DarioHealth Corp. proceeds from issuance or sale of equity for fiscal 2020 was $27.55M, a 9.11% increase from fiscal 2019.
- DarioHealth Corp. proceeds from issuance or sale of equity for fiscal 2019 was $25.25M, a 34.70% increase from fiscal 2018.
- DarioHealth Corp. proceeds from issuance or sale of equity for fiscal 2018 was $18.74M.
| Period end | Proceeds from Issuance or Sale of Equity 3 month | Proceeds from Issuance or Sale of Equity 6 month | Proceeds from Issuance or Sale of Equity 9 month | Proceeds from Issuance or Sale of Equity 12 month |
|---|---|---|---|---|
| 2025-06-30 | $6.75M 10-Q · filed 2026-08-11 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-09 | $27.55M derived: sum of 2 quarters · filed 2021-03-09 | $27.55M 10-K · filed 2021-03-09 | |
| 2020-09-30 | $27.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $27.55M 10-Q · filed 2020-11-12 | ||
| 2020-06-30 | $0.00 10-Q · filed 2020-08-12 | |||
| 2019-12-31 | $18.69M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-09 | $18.69M derived: sum of 2 quarters · filed 2021-03-09 | $25.25M 10-K · filed 2021-03-09 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $6.56M 10-Q · filed 2020-11-12 | ||
| 2019-06-30 | $6.56M 10-Q · filed 2020-08-12 | |||
| 2018-12-31 | $18.74M 10-K · filed 2020-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |